| O’Grady et al.17 LoE†: VII USA/2002 |
Review, guideline |
To create a guideline for the prevention of infections related to intravascular catheters. |
Hand hygiene. |
| Maki, Crnich18 LoE†: VII USA/2003 |
Review |
To identify the risks of healthcare-related infections caused by catheters in intensive care. |
Skin antisepsis. |
| Cousins, O’Donnel19 LoE†: V USA/2004 |
Review |
To examine the radial, brachial, axillary and femoral arterial puncture sites. |
Puncture site. |
| Koh et al.20 LoE†: VI Australia/ 2008 |
Descriptive, quantitative, observational |
To measure colonization and rates of catheter-related bloodstream infection in arterial catheters. |
The choice of the radial artery without specifying which side of the limb. Infection rate. |
| Martins et al.21 LoE†: VI Brazil/2008 |
Descriptive, observational |
To verify nursing professionals adherence to asepsis recommendations when installing and handling the PVC**. |
Skin antisepsis. |
| Small et al.22 LoE†: II United Kingdom/2008 |
Randomized clinical trial |
To compare the effectiveness of 2% chlorhexidine gluconate in 70% isopropyl alcohol and 70% isopropyl alcohol for skin disinfection to prevent catheter-related healthcare-related infections. |
Skin antisepsis. |
| Lee et al.23 LoE†: II Taiwan/2009 |
Randomized clinical trial |
To examine whether the scheduled change interval from 48 to 72 hours to 72 to 96 hours is a risk factor for PVC** infection. |
Skin antisepsis. |
| López et al.24 LoE†: II Spain/2009 |
Randomized clinical trial |
To investigate the clinical performance of a closed infusion system compared to an open system in PVC**. |
For skin antisepsis, 70% alcohol. |
| Lemaster et al.25 LoE†: V USA/2010 |
Systematic review |
To carry out a systematic review of CVC§ and PAC‡‡ studies inserted in emergencies. |
Invasive line in emergency sectors and maximum barrier precautions. |
| Koh et al.26 LoE†: IV Australia/2012 |
Descriptive, quantitative, prospective and observational |
To determine catheter colonization rates after removal. |
Skin antisepsis, maximum sterile barrier, sterile drape and glove. |
| Vezzani et al.27 LoE†: VI Italy/2013 |
Descriptive, prospective, observational, review |
To use ultrasound as a guide during vascular access procedures. |
Ultrasound use, Allen test. |
| López et al.28 LoE†: II Spain/2014 |
Randomized clinical trial |
To compare closed system PVC** with open system PVC**. |
Skin antisepsis. |
| Calero et al. 29 LoE†: V Spain/2015 |
Systematic review |
To establish which antiseptic solution is most suitable for skin antisepsis to prevent healthcare-related infections caused by catheter use. |
Skin antisepsis. |
| Melo, et al.30 LoE†: VI Brazil/2015 |
Descriptive |
To analyze the care provided by nursing professionals during peripheral venipuncture. |
Skin antisepsis. |
| Choudhury et al.31 LoE†: II Australia/2016 |
Randomized clinical trial |
To determine bacterial community structures in the skin at insertion sites and associated PVC**. |
Skin antisepsis. |
| Evans et al.32 LoE†: IV Australia/2016 |
Descriptive, quantitative, comparative |
To assess the sensitivity, specificity and accuracy of two in situ diagnostic methods for healthcare-related infection prevention related to catheter use in adults hospitalized for burns. |
Skin antisepsis, sterile technique, maximum protection barriers, ultrasound use. |
| Kiefer, Keller, Weekes33 LoE†: VI USA/2016 |
Descriptive and prospective |
To assess the immediate and short-term incidence of complications from catheters in the internal jugular vein. |
Ultrasound use. |
| Zhang et al.34 LoE†: VI Australia/2016 |
Descriptive, quantitative |
To assess the results of bacteriological culture of intravascular catheters. |
PAC‡‡ colonization. |
| Marsh et al.35 LoE†: II Australia/2018a |
Randomized clinical trial |
To compare two coverage methods for PVC**. |
Skin antisepsis. |
| Rickard et al.36 LoE†: II Australia/2018 |
Randomized clinical trial |
To compare the effectiveness and costs of three types of PVC** polyurethane dressings. |
Skin antisepsis. |
| Timsit et al.37 LoE†: V France/2018 |
Review |
To provide updated information on available knowledge on the epidemiology and diagnosis of CVC§ and PAC‡‡ complications in the Intensive Care Unit. |
Ultrasound use. |
| Bakan, Arli38 LoE†: No categorization Turkey/2019 |
Methodological study, review |
To develop a scale to assess nurses’ knowledge and attitudes about healthcare-related infection prevention related to PVC** and CVC§ use. |
Hand hygiene before and after insertion; antiseptic and glove use. |
| Choudhury et al.39 LoE†: VI Australia/2019 |
Descriptive, quantitative |
To assess the impact of PVC** insertion site colonization and the occurrence of primary bloodstream infections. |
Skin antisepsis. |
| Lanza et al.40 LoE†: VI Brazil/2019 |
Descriptive |
To analyze nursing professionals’ adherence to preventive measures for PVC** infection. |
Skin antisepsis. |
| Parreira et al. 41 LoE†: III Portugal/2019 |
Clinical trial |
To assess the impact of single-use disposable tourniquets and polyurethane dressings with reinforced edges on the occurrence of complications related to PVC** use. |
Skin antisepsis. |
| Simin et al.42 LoE†: IV Serbia/ 2019 |
Descriptive |
To determine the incidence, severity, and risk factors of PVC**-induced complications. |
For skin antisepsis, 70% alcohol. |
| Simonetti et al.43 LoE†: VI Italy/2019 |
Descriptive, cross-sectional |
To determine nursing students’ theoretical knowledge about evidence-based guidelines for managing PVC** insertion and investigate potential predictive factors associated with adherence to recommendations. |
Skin antisepsis. |
| Buetti et al. 44 LoE†: IV France/2020 |
Descriptive, quantitative, comparative |
To compare the use of two types of chlorhexidine gluconate-impregnated dressings for primary bloodstream infections prevention. |
Skin antisepsis, hand antisepsis, sterile glove, sterile field, mask and gown use. |
| Keogh et al. 45 LoE†: II Australia/2020 |
Randomized clinical trial |
To assess the impact of a multifaceted intervention focused on PVC** maintenance. |
Skin antisepsis. |
| Jiménez-Martínez et al.46 LoE†: VI M exico/2020 |
Descriptive |
To analyze the benefits of cleaning the PVC** insertion site as a measure to maintain a functional short PVC** as a maintenance option. |
Skin antisepsis. |
| Larsen et al. 47 LoE†: IV Australia/2020 |
Descriptive, prospective cohort |
To identify modifiable and non-modifiable risk factors for PVC** failure. |
Skin antisepsis, sterile gloves and sterile, disposable transducer kit. |
| Liu et al. 48 LoE†: VI China/2020 |
Descriptive |
To identify the incidence, risk factors, and medical costs of complications related to PVC** use. |
Skin antisepsis. |
| Pérez-Granda et al.49 LoE†: II Spain/2020 |
Randomized clinical trial |
To compare the phlebitis and colonization rates of PVC** tip. |
Monitor the insertion site, skin antisepsis, 2% alcoholic chlorhexidine, connector disinfection, hand hygiene, change of gauze/dressing. |
| Schults et al.50 LoE†: VI Australia/2020 |
Descriptive, quantitative, observational |
To describe PAC‡‡ insertion and management practices and associated complications. |
Skin antisepsis and ultrasound use. |
| Takahashi et al.51 LoE†: II Japan/2020 |
Controlled clinical trial |
To establish and assess an intervention method of a package of measures to prevent catheter failures. |
Ultrasound use. |
| Timsit et al.52 LoE†: VII France/2020 |
Review, guideline |
To develop guidelines for CVC§, PAC‡‡ and dialysis catheter management in the Intensive Care Unit. |
Skin antisepsis. |
| Vendramim et al.53 LoE†: II Brazil/2020 |
Randomized clinical trial |
To investigate the non-inferiority of clinically indicated PVC** replacement compared to routine replacement, every 96 hours, to prevent phlebitis. |
Skin antisepsis. |
| Blanco-Mavillard et al.54 LoE†: II Spain/2021 |
Randomized clinical trial |
To determine the effectiveness and costs of a multimodal intervention to reduce PVC** failure. |
Skin antisepsis. |
| Larsen et al.55 LoE†: II Australia/2021 |
Randomized clinical trial |
To compare PAC‡‡ dressing and fixation methods to prevent device failure in adult Intensive Care Unit. |
Skin antisepsis, sterile gloves, lidocaine use. |
| Rickard et al.56 LoE†: II Australia/2021 |
Randomized clinical trial |
To compare the effectiveness and costs of 7-day versus 4-day infusion set replacement to prevent catheter-related primary bloodstream infections. |
Skin antisepsis, sterile field and sterile glove use. |